KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Enterprise Value (2016 - 2025)

Evolent Health (EVH) has 11 years of Enterprise Value data on record, last reported at -$140.3 million in Q3 2025.

  • For Q3 2025, Enterprise Value fell 24.28% year-over-year to -$140.3 million; the TTM value through Sep 2025 reached -$140.3 million, down 24.28%, while the annual FY2024 figure was -$163.5 million, 20.86% up from the prior year.
  • Enterprise Value reached -$140.3 million in Q3 2025 per EVH's latest filing, up from -$175.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$112.9 million in Q3 2024 and bottomed at -$342.0 million in Q4 2021.
  • Average Enterprise Value over 5 years is -$210.7 million, with a median of -$206.6 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: crashed 136.59% in 2021, then skyrocketed 45.64% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$342.0 million in 2021, then soared by 40.73% to -$202.7 million in 2022, then decreased by 1.92% to -$206.6 million in 2023, then grew by 20.86% to -$163.5 million in 2024, then rose by 14.16% to -$140.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$140.3 million in Q3 2025, -$175.4 million in Q2 2025, and -$262.7 million in Q1 2025.